These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Mullen MJ; Hildick-Smith D; De Giovanni JV; Duke C; Hillis WS; Morrison WL; Jux C Circulation; 2006 Oct; 114(18):1962-7. PubMed ID: 17062781 [TBL] [Abstract][Full Text] [Related]
5. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage. Majunke N; Wallenborn J; Wunderlich N; Sievert H Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522 [TBL] [Abstract][Full Text] [Related]
6. The BioSTAR(r) device versus the CardioSEAL(r) device in patent foramen ovale closure: comparison of mid-term efficacy and safety. Van den Branden BJ; Luermans JG; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ EuroIntervention; 2010 Sep; 6(4):498-504. PubMed ID: 20884438 [TBL] [Abstract][Full Text] [Related]
7. Late tamponade secondary to aortic root perforation by BioSTAR septal closure device. Cikirikcioglu M; Cherian S; Lerch R; Licker MJ; Roffi M; Bonvini RF; Kalangos A Ann Thorac Surg; 2011 Feb; 91(2):604-6. PubMed ID: 21256328 [TBL] [Abstract][Full Text] [Related]
8. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. Jux C; Bertram H; Wohlsein P; Bruegmann M; Paul T J Am Coll Cardiol; 2006 Jul; 48(1):161-9. PubMed ID: 16814662 [TBL] [Abstract][Full Text] [Related]
9. Patent foramen ovale: clinical manifestations and treatment. Kedia G; Tobis J; Lee MS Rev Cardiovasc Med; 2008; 9(3):168-73. PubMed ID: 18953276 [TBL] [Abstract][Full Text] [Related]
10. ASD/PFO devices: what is in the pipeline? Majunke N; Sievert H J Interv Cardiol; 2007 Dec; 20(6):517-23. PubMed ID: 18042057 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ; J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ; Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure. Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251 [TBL] [Abstract][Full Text] [Related]